Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis

被引：14

作者：

Chelli, Clara ^{[1
]}

Loget, Jeffrey ^{[1
]}

Vanhaecke, Clelia ^{[1
]}

Durlach, Anne ^{[2
]}

Gagneux-Lemoussu, Laurence ^{[3
]}

Soriano, Clothilde ^{[4
]}

Viguier, Manuelle ^{[1
]}

机构：

[1] Robert Debre Hosp, Dept Dermatol Venereol, Ave Gen Koenig, FR-51092 Reims, France

[2] Robert Debre Hosp, Dept Gastrol, Ave Gen Koenig, FR-51092 Reims, France

[3] Reims Univ Hosp, Maison Blanche Hosp, Biopathol, Reims, France

[4] Reims Univ Hosp, Maison Blanche Hosp, Dept Rheumatol, Reims, France

来源：

ACTA DERMATO-VENEREOLOGICA | 2020年 / 100卷 / 03期

关键词：

D O I：

10.2340/00015555-3435

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1 / 2

页数：2

共 14 条

[1]

Abrouk M, 2017, Skin Therapy Lett, V22, P1

[2] Etiology and Pathogenesis of Psoriatic Arthritis [J].

Barnas, Jennifer L. ;

Ritchlin, Christopher T. .

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (04) :643-+

[3]

Clark ML, 2018, Case Rep Dermatol Med, V2018

[4] Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial [J].

Hueber, Wolfgang ;

Sands, Bruce E. ;

Lewitzky, Steve ;

Vandemeulebroecke, Marc ;

Reinisch, Walter ;

Higgins, Peter D. R. ;

Wehkamp, Jan ;

Feagan, Brian G. ;

Yao, Michael D. ;

Karczewski, Marek ;

Karczewski, Jacek ;

Pezous, Nicole ;

Bek, Stephan ;

Bruin, Gerard ;

Mellgard, Bjoern ;

Berger, Claudia ;

Londei, Marco ;

Bertolino, Arthur P. ;

Tougas, Gervais ;

Travis, Simon P. L. .

GUT, 2012, 61 (12) :1693-1700

[5] Psoriatic Arthritis and Burden of Disease: Patient Perspectives from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey [J].

Kavanaugh A. ;

Helliwell P. ;

Ritchlin C.T. .

Rheumatology and Therapy, 2016, 3 (1) :91-102

[6]

Mease PJ, 2018, RMD OPEN

[7] Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE) [J].

Mrowietz, Ulrich ;

Leonardi, Craig L. ;

Girolomoni, Giampiero ;

Toth, Darryl ;

Morita, Akimichi ;

Balki, Shyamal A. ;

Szepietowski, Jacek C. ;

Regnault, Pascaline ;

Thurston, Helen ;

Papavassilis, Charis .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (01) :27-U109

[8]

Papp K, 2015, J DRUGS DERMATOL, V14, P58

[9]

Puig Lluis, 2018, Curr Probl Dermatol, V53, P49, DOI 10.1159/000479475

[10] Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors [J].

Sokumbi, Olayemi ;

Wetter, David A. ;

Makol, Ashima ;

Warrington, Kenneth J. .

MAYO CLINIC PROCEEDINGS, 2012, 87 (08) :739-745

← 1 2 →